The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019. Issue 2 (24th August 2020)

• Record Type: Journal Article
• Authors: Ascierto, Paolo A; Bifulco, Carlo; Galon, Jerome; Garbe, Claus; Khleif, Samir N; McQuade, Jennifer; Odunsi, Kunle; Okada, Hideho; Paulos, Chrystal M; Quezada, Sergio A; Tawbi, Hussein A; Timmerman, John; Trinchieri, Giorgio; Butterfield, Lisa H; Puzanov, Igor
• Is Part Of: Journal for immunotherapy of cancer. Volume 8:Issue 2(2020)
• Publication Date: 2020-08-24
• Subjects: cytotoxicity -- immunologic -- CTLA-4 antigen -- immunotherapy -- receptors -- chimeric antigen; Cancer -- Immunotherapy -- Periodicals; Cancer -- Immunological aspects -- Periodicals; Tumors -- Immunological aspects -- Periodicals; Immunotherapy -- Periodicals; 616.99406105
• DOI: 10.1136/jitc-2020-000921
• Languages: English
• ISSNs: 2051-1426

Abstract

Abstract : As part of the 2019 Immunotherapy Bridge congress (December 4–5, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on six topical issues in immunotherapy today. These were the use of chimeric antigen receptor T cell therapy in solid tumors, whether the Immunoscore should be more widely used in clinical practice, whether antibody-dependent cellular cytotoxicity is important in the mode of action of anticytotoxic T-lymphocyte-associated protein 4 antibodies, whether the brain is immunologically unique or just another organ, the role of microbiome versus nutrition in affecting responses to immunotherapy, and whether chemotherapy is immunostimulatory or immunosuppressive. Discussion of these important topics are summarized in this report.